ARTICLE | Clinical News
Vectibix panitumumab regulatory update
April 20, 2015 7:00 AM UTC
The European Commission approved an expanded label for Vectibix panitumumab from Amgen to include first-line treatment of wild-type Ras metastatic colorectal cancer (mCRC) in combination with FOLFIRI...